Publications
Select keywords to filter the posts for matching content:
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time
StudyTAURUS-MS II
Year2024
KeywordsInspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices
StudyinspeCKD
Year2024
Keywords- CKD
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
StudyYear2023
Keywords- HER2
- breast cancer
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
StudyYear2023
Keywords- breast cancer
Incidental Pulmonary Nodules - What Do We Know in 2022
StudyYear2022
Keywords- lung cancer
A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients with Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE
StudyGO ACTIVE
Year2022
Keywords- rheumatoid arthritis
- psoriatic arthritis
- axial spondyloarthritis
- golimumab
- QoL
- WPAI
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.
StudyDETECT
Year2021
Keywords- breast cancer
- liquid biopsy
- HER2
- oncology
Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.
StudyGo CUTE II
Year2021
Keywords- golimumab
- ulcerative colitis
- QoL
- WPAI
- HCRU
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study i
StudyMC Productive
Year2021
Keywords- Crohn's disease
- infliximab
- QoL
- WPAI
- HRQoL
Neoadjuvant and adjuvant end-points in health technology assessment in oncology.
StudyAMNOG
Year2021
Keywords- immunotherapy
- oncology